Construction and characterization of a stably transformed HeLa cell line in which the expression of bovine herpesvirus 1 ICP0 (BICP0) is induced by tetracycline

Archives of Virology

Volumn 143, Issue 1, 1998, Pages 35-48

  Steinmann, N A ^a   Nunez R ^a   Koppel R ^a   Ackermann, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BICP0 PROTEIN, BOVINE HERPESVIRUS 1; PROTEIN SYNTHESIS INHIBITOR; RECOMBINANT PROTEIN; TETRACYCLINE; THYMIDINE KINASE; TRANSACTIVATOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VIRUS DNA; VIRUS PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; LONG TERMINAL REPEAT; METABOLISM; OPERATOR GENE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; TRANSACTIVATION; VIRUS GENE;

CELL LINE, TRANSFORMED; DNA, VIRAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HELA CELLS; HERPESVIRUS 1, HUMAN; HIV LONG TERMINAL REPEAT; HUMANS; OPERATOR REGIONS (GENETICS); POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; RECOMBINANT PROTEINS; TETRACYCLINE; TETRACYCLINE RESISTANCE; THYMIDINE KINASE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 1; DNA VIRUSES; HERPES; HERPESVIRIDAE; HERPESVIRUS 1; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031907595     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050266     Document Type: Article

References (31)

1. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268: 582-583
2. Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D (1996) Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis 173: 248-251
3. Crameri A, Stemmer WPC (1995) Efficacy of tetracycline-controlled gene expression is influenced by cell type. Bio Techniques 18: 196-200
4. Fraefel C, Zeng J, Choffat Y, Engels M, Schwyzer M, Ackermann M (1994) Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. J Virol 68: 3154-3162
5. Geng Y, Kashanchi F, Wood C (1992) Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1. Virology 187: 832-836
6. Gimble JM, Duh E, Ostrove JM, Gendelman HE, Max EE, Rabson AB (1988) Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-κB/core enhancer sequence. J Virol 62: 4104-4112
7. Gossen M, Bonin AL, Bujard H (1993) Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. TIBS 18: 471-475
8. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551
9. Herring AJ, Sharp JM, Scott FMM, Angus KW (1983) Further evidence for a retrovirus as the aetiological agent of sheep pulmonary adenomatosis (jaagsiekte). Vet Microbiol 8: 237-249
10. Hossain A, Schang LM, Jones C (1995) Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. J Virol 69: 5345-5352
11. Howe HR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C (1995) The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 270: 14168-14174
12. Johnston RF, Pickett SC, Barker DL (1990) Autoradiography using storage phosphor technology. Electrophoresis 11: 355-360
13. Kawaguchi Y, Miyazawa T, Horimoto T, Itagaki S-I, Masashi F, Takahashi E, Mikami T (1991) Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1. Virology 184: 449-454
14. Koppel R, Fraefel C, Vogt B, Bello LJ, Lawrence WC, Schwyzer M (1996) Recombinant bovine herpesvirus-1 (BHV-1) lacking transactivator protein BICP0 entails lack of glycoprotein C and severely reduced infectivity. Biol Chem 377: 787-795
15. Koppel R, Vogt B, Schwyzer M (1997) Immediate-early protein BICP22 of bovine herpesvirus 1 trans-represses viral promoters of different kinetic classes and is itself regulated by BICP0 at transcriptional and posttranscriptional levels. Arch Virol 142: 2447-2464
16. Kutish G, Mainrize T, Rock D (1990) Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J Virol 64: 5730-5737
17. Luciw PA (1996) Human immunodeficiency viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology, vol. 2, 3rd ed. Lippincott-Raven, Philadelphia, pp 1881-1952
18. Margolis DM, Ostrove JM, Straus SE (1993) HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology 192: 370-374
19. Margolis DM, Rabson AB, Straus SE, Ostrove JM (1992) Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology 186: 788-791
20. Metzler AE, Schudel AA, Engels M (1986) Bovine herpesvirus 1: molecular and anti-genetic characteristics of variant viruses isolated from calves with neurological disease. Arch Virol 87: 205-217
21. Miles SA (1994) Pathogenesis of HIV-related Kaposi's sarcoma (review). Curr Opin One 6: 497-502
22. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski WA, Haseltine WA, Pitha PM (1987 a) Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325: 67-70
23. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski WA, Haseltine WA, Hayward GS, Pitha PM (1987 b) Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc Natl Acad Sci USA 84: 7408-7412
24. Nabel GJ, Rice SA, Knipe DM, Baltimore D (1988) Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 230: 1299-1302
25. Ostove JM, Leonard J, Weck KE, Rabson AB, Gendelman HE (1987) Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol 61: 3726-3732
26. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679
27. Samaniego LA, Wu N, DeLuca NA (1997) The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 71: 4614-4625
28. Schang LM, Hossain A, Jones C (1996) The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol 70: 3807-3814
29. Vlach J, Pitha PM (1992) Herpes simplex virus type 1- mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-κB enhancer and leader sequence. J Virol 66: 3616-3623
30. Vlach J, Pitha PM (1993) Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus. J Virol 67: 4427-4431
31. Wirth UV, Fraefel C, Vogt B, Vlcek C, Paces V, Schwyzer M (1992) Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3′ coterminal and encode a putative zinc finger transactivator protein. J Virol 66: 2763-2772